Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Gross Profit (2022 - 2025)

Envoy Medical's Gross Profit history spans 4 years, with the latest figure at -$136000.0 for Q4 2025.

  • Quarterly results put Gross Profit at -$136000.0 for Q4 2025, down 126.36% from a year ago — trailing twelve months through Dec 2025 was -$967000.0 (down 180.29% YoY), and the annual figure for FY2025 was -$633000.0, down 22.44%.
  • Gross Profit for Q4 2025 was -$136000.0 at Envoy Medical, up from -$363000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $516000.0 in Q4 2024 to a low of -$429000.0 in Q2 2024.
  • The 4-year median for Gross Profit is -$137500.0 (2023), against an average of -$152285.7.
  • Peak annual rise in Gross Profit hit 471.22% in 2024, while the deepest fall reached 333.33% in 2024.
  • Year by year, Gross Profit stood at -$131000.0 in 2022, then decreased by 6.11% to -$139000.0 in 2023, then surged by 471.22% to $516000.0 in 2024, then plummeted by 126.36% to -$136000.0 in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at -$136000.0, -$363000.0, and -$156000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.